Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-06-18 @ 2:28 AM
Study NCT ID:
NCT07349069
Status:
RECRUITING
Last Update Posted:
2026-03-19
First Post:
2026-01-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With High-Risk Early Breast Cancer
Sponsor:
Shandong Suncadia Medicine Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |
Keywords: